Neurology

HIF-1α is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis

18 hours ago   |   Springer

Abstract Bacterial meningitis is a deadly disease most commonly caused by Streptococcus pneumoniae , leading to severe neurological sequelae including cerebral edema, seizures...
Read more ...

Gastruloids Stand In for Early Human Embryos

5 days ago   |   DNA Science

Remember human embryonic stem cells? We don't hear much about them anymore. And so I was surprised to see an application of the controversial cells to grow human embryo-like...
Read more ...

AveXis Inc.: Manager, Research Quality Assurance

12 days ago   |   San Diego Biotechnology   |   2 articles

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases

Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases

13 days ago   |   Xconomy

The blood-brain barrier protects the functioning of that essential organ, but it's also a hurdle to delivering neurological drugs. Italy's Chiesi Group has agreed to pay...
Read more ...

Social Human-Robot Interaction for Gait Rehabilitation

14 days ago   |   EMBS

Robot-assisted therapy for gait rehabilitation of patients with neurological disorders usually combines a body weight support system with a treadmill system. Lokomat is one of...
Read more ...

Casting a wider net: New system measures brain activity of several zebrafish concurrently

15 days ago   |   Phys

Before a drug can be used to treat patients, it goes through several rounds of testing for efficacy and toxicity, which begin in animal models. Zebrafish, a tiny species of...
Read more ...

Designer peptides show potential for blocking viruses, encourage future study

17 days ago   |   ScienceDaily

Chemically engineered peptides could prove valuable in the battle against some of the most persistent human health challenges. New findings demonstrate how researchers can...
Read more ...

AveXis Inc.: Scientist II, Potency Assay Development

19 days ago   |   San Diego Biotechnology   |   5 articles

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

AveXis Inc.: Principal Investigator, Ultra-Rare Disease Program Lead, R&D

20 days ago   |   San Diego Biotechnology   |   2 articles

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

Mitochondrial reactive oxygen species cause major oxidative mitochondrial DNA damages and repair pathways

21 days ago   |   Journal of Biosciences

Abstract Mitochondria-derived reactive oxygen species are produced at a variety of sites and affect the function of bio-molecules. The anti-oxidant system from both...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

After Biologic COVID-19 Drug OK'd in India, Equillium Plans a US Test

After Biologic COVID-19 Drug OK'd in India, Equillium Plans a US Test

The drug that Equillium licensed from India-based pharma giant Biocon has received authorization for emergency use in that country in patients hospitalized with COVID-19. The... Read more ...

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact

A Blueprint Medicines cancer drug candidate currently under FDA review will have the marketing muscle of Roche behind it if it wins regulatory approval. The two companies are... Read more ...

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Last Chance for Xconomy Awards Nominations - Deadline is Friday, July 17

Have you had your say yet? The 2020 National Xconomy Awards represent the very best our life science industry has to offer. It is our privilege to recognize emerging companies... Read more ...

New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on...

New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health

Miss Xconomy's Xcelerating Life Sciences Boston: Biopharma's Future in Digital Health event or want to revisit the insightful content? Our new podcast and special report... Read more ...

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

Amgen Doubles Down on BeiGene Collaboration, Investing $421M More

At the year's start Thousand Oaks, CA-based Amgen closed a strategic collaboration with BeiGene, investing $2.8 billion to gain a presence in what's becoming an ever-more... Read more ...

Scientists Successfully Demonstrate a New Experiment in the Search for...

Scientists Successfully Demonstrate a New Experiment in the Search for Theorized ‘Neutrinoless' Process

The CUPID-Mo detector is installed in the Edelweiss cryostat at Modane Underground Laboratory in France. Nuclear physicists affiliated with the U.S. Department of Energy's... Read more ...

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments

Three biotech companies collectively raised $584 million in their initial public offerings last week, continuing a streak of IPOs that has the healthcare sector playing a... Read more ...

Inverse Liquid Solid Chromatography to Evaluate Drug Interactions with...

Abstract Body‐on‐a‐chip and organ‐on‐a‐chip systems utilize polydimethylsiloxane because of the relative suitability of the material for fabrication of microfluidic channels... Read more ...

Oncology Account Manager - West | San Diego, CA - Oncopeptides North America...

About Oncopeptides: Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological cancers...From Oncopeptides... Read more ...

De novo resveratrol production through modular engineering of an Escherichia...

Resveratrol is a plant secondary metabolite with diverse, potential health-promoting benefits. Due to its nutraceutical merit, bioproduction of resveratrol via microbial... Read more ...